Establishing proficient and efficient communication with region-specific Ministries of Health (MOHs) or equivalent health agencies is essential while navigating medical device approvals. Each country has its own set of mandated documents, communication, and language protocols. If not managed compliantly, there is a risk of delay in approvals and it in turn impacts the device’s time-to-market.
Vigilare’s regulatory team is spread across nations, which gives us a competitive edge in understanding local nuances for MOH interactions and regulatory liaison support. Leveraging our experience in managing regulatory agency communications, from pre-market consultations to audit responses and post-market commitments, we ensure effective and timely engagement with health authorities worldwide. We support device manufacturers with in-person meetings with MOH, decoding submission feedback and queries, and labeling and technical file translations.
We support and represent our clientele across the MOH approval process. We ensure that required regulatory steps are precisely followed and assist with:
Unparallel support for review cycles
With Vigilare, communication in the local language is never a barrier to dealing with local MOHs or health authorities. We ensure 100% accuracy in translation with:
Submission clarifications
Without direct representation in person, few regulatory reviews will be challenging. Vigilare has a presence across 100+ countries, and is equipped for:
Assistance during agency audits or site inspections
Vigilare representatives assist device manufacturers with accurate information translations, especially for labeling documentation and technical files. We aim to avoid regulatory delays with accurate interpretations. Our translation services include:
Compliance with local labeling templates
